Mr. Alroy re-joined the SHL Board of Directors as a non-executive Director in 2016. Mr. Alroy served in various executive positions in SHL Telemedicine since its inception, as its Co-CEO from 2000 to January 2015 and as a director from 2008 to 2014.He is currently active in various investments and is a board member in Merhavia Holdings Ltd (TASE:MRHL) and is the Chairman of Migvan Engineering and Technology Ltd.Mr. Alroy holds an MBA from the Hebrew University in Jerusalem. Nationality: Israeli.
Dr. Amir Lerman
Dr. Lerman joined the Board of Directors of SHL as a non-executive Director in 2016. Dr. Lerman is the Director of the Cardiovascular Research Center at the Mayo Clinic in Rochester (USA) since 2013. He is also the Program Director for vascular and valve, Center for Regenerative Medicine at the Mayo Clinic, since 2012, and Vice-Chair, Cardiovascular Department and chair for Cardiovascular research at the Mayo Clinic, since 2013. In addition, Dr. Lerman serves as the Director of the Mayo-Israeli start up company initiative as well as a faculty member at the Mirage Institute: US-Israel innovation bridge business leadership program, since 2009, in addition to various other positions held at the Mayo Clinic. Dr. Lerman also holds an appointment as Professor of Medicine at the Mayo Medical School since 2001. Dr. Lerman graduated from the Technion school of Medicine in Haifa Israel in 1985 and completed his training in internal medicine, cardiovascular diseases and invasive cardiology at the Mayo Clinic in 1994. Dr. Lerman published more than 500 manuscripts, book chapters and reviews; the NIH, AHA, and several foundations support his research. Nationality: American/ Israeli.